Program Overview

Pharmacology of Treatment of Metabolic Disease Module

Overview

The Pharmacology of Treatment of Metabolic Disease module (BS42028) is a research-led teaching module that covers key topics in the clinical pharmacology of treatment of obesity, diabetes, fatty liver disease, and metabolic diseases of the brain.

Module Details

• Credits: 15
• Module code: BS42028
• Level: 4
• Semester: Semester 2
• School: School of Life Sciences
• Discipline: D'Arcy Thompson Unit

Module Aims

This module aims to provide advanced research-led teaching of key topics in the clinical pharmacology of treatment of metabolic diseases. It builds on specialized areas of physiology, biochemistry, molecular cell biology, and genetics encountered in previous modules.

Learning Outcomes

Following successful completion of this module, students will be able to explain and critically appraise central concepts in the field of pharmacology of treatments for metabolic diseases and associated health complications.

Topics Covered

• Glucose metabolism and different types of diabetes
• Pathophysiology of different types of diabetes
• Current approaches to treatment of metabolic diseases
• Medical complications of diabetes and their treatment
• Mechanisms of action of commonly prescribed diabetes drugs
• Diabetes pharmacogenetics
• Personalized medicine for diabetes
• Molecular and clinical aspects of fatty liver disease and hepatitis
• Metabolic diseases of the brain
• Important aspects of clinical trial design
• New treatments on the horizon

Available Courses

This module is available on the following courses:

• Biomedical Sciences (with a year in industry) BSc (Hons)
• Pharmacology BSc (Hons)
• Biomedical Sciences BSc (Hons)
• Pharmacology (with a year in industry) BSc (Hons)
• Biological and Biomedical Sciences (joint degree with National University of Singapore) BSc (Hons)